You are here

PA32540

Pozen Resubmits PA NDA, PDUFA In Two Months?

Seeking Alpha

Thu, 07/3/14 - 10:42 am

Sanofi will sell Pozen cardiovascular drugs in US

Yahoo/AP

Thu, 09/5/13 - 08:20 am

cardiovascular disease

POZEN's NDA for PA32540/PA8140 tablets accepted by FDA for review

Yahoo/Fly on the Wall

Wed, 05/29/13 - 08:49 am

POZEN Submits New Drug Application for PA32540/PA8140

Yahoo

Wed, 03/27/13 - 11:41 am

proton pump inhibitors

POZEN's PA32540 shows posiive results in a Phase 1 study

Yahoo/Fly on the Wall

Thu, 08/30/12 - 09:41 am

Pozen rises on continued FDA drug discussions

Yahoo/AP

Fri, 08/24/12 - 06:30 pm

FDA says Pozen ulcer drug may need more data, shares plunge

Reuters

Thu, 06/21/12 - 07:42 am

PA32540 Provides Faster Gastric Acid Reduction Than Enteric-Coated Omeprazole (40 Mg)

The Street

Sat, 05/19/12 - 12:29 pm

Pozen rises as ulcer drug meets goals in studies

Yahoo/AP

Thu, 03/22/12 - 11:24 am

Pozen's Final Results On Ulcer Safe Aspirin Can Send Shares Soaring

Seeking Alpha

Tue, 03/20/12 - 10:15 am

Change of heart: Why Pozen now wants to partner its cardiovascular drug

Med City

Wed, 10/5/11 - 10:59 am